
Sign up to save your podcasts
Or


Andrew Slimmon, Morgan Stanley Investment Management Senior Portfolio Manager, says it is way too early to get bearish. Dr. Amesh Adalja, Johns Hopkins Center for Health Security Senior Scholar, says getting only a mild illness from Covid-19 is a victory for vaccines. Sarah Hunt, Alpine Woods Capital Investors Portfolio Manager, says growth is going to continue to be important for equity markets. Neil Dutta, Renaissance Macro Research U.S. Economic Research Head, says the Fed could hike four times next year without being hawkish.
See omnystudio.com/listener for privacy information.
By Bloomberg3.9
11081,108 ratings
Andrew Slimmon, Morgan Stanley Investment Management Senior Portfolio Manager, says it is way too early to get bearish. Dr. Amesh Adalja, Johns Hopkins Center for Health Security Senior Scholar, says getting only a mild illness from Covid-19 is a victory for vaccines. Sarah Hunt, Alpine Woods Capital Investors Portfolio Manager, says growth is going to continue to be important for equity markets. Neil Dutta, Renaissance Macro Research U.S. Economic Research Head, says the Fed could hike four times next year without being hawkish.
See omnystudio.com/listener for privacy information.

981 Listeners

409 Listeners

2,192 Listeners

1,997 Listeners

435 Listeners

969 Listeners

193 Listeners

186 Listeners

69 Listeners

1,313 Listeners

65 Listeners

81 Listeners

30 Listeners

62 Listeners

4 Listeners

58 Listeners

233 Listeners

228 Listeners

63 Listeners

86 Listeners

81 Listeners

83 Listeners

81 Listeners

408 Listeners

22 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

24 Listeners